Caitlin Creasy
#191,685
Most Influential Person Now
Researcher, ORCID id # 0000-0002-6271-0337
Caitlin Creasy's AcademicInfluence.com Rankings
Caitlin Creasycomputer-science Degrees
Computer Science
#13328
World Rank
#14339
Historical Rank
Computational Linguistics
#3326
World Rank
#3370
Historical Rank
Machine Learning
#6232
World Rank
#6344
Historical Rank
Artificial Intelligence
#6701
World Rank
#6836
Historical Rank
Download Badge
Computer Science
Caitlin Creasy's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Caitlin Creasy Influential?
(Suggest an Edit or Addition)Caitlin Creasy's Published Works
Published Works
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. (2016) (1018)
- PD-L1 expression and prognostic impact in glioblastoma. (2016) (410)
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. (2018) (337)
- Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy (2020) (97)
- Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome (2018) (77)
- 24 Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma (2018) (68)
- Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy (2014) (47)
- Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade (2017) (44)
- 4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer (2017) (38)
- IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation (2016) (33)
- SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity (2017) (25)
- Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma (2018) (24)
- Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues (2021) (16)
- Thoracic and abdominal lymphatic pump techniques inhibit the growth of S. pneumoniae bacteria in the lungs of rats. (2013) (15)
- Lymphatic Pump Treatment as an Adjunct to Antibiotics for Pneumonia in a Rat Model (2015) (13)
- Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy (2021) (12)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts (2016) (12)
- Abstract 4363: Loss of PTEN promotes resistance to T cell-mediated immunotherapy (2016) (8)
- Exposure to anti‐PD‐1 causes functional differences in tumor‐infiltrating lymphocytes in rare solid tumors (2019) (4)
- Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy (2014) (4)
- IMPS-28PD-L1 EXPRESSION AND PROGNOSTIC IMPACT IN GLIOBLASTOMA (2015) (3)
- Bivalent and Broad Chromatin Domains Regulate Pro-metastatic Drivers in Melanoma (2019) (3)
- Multi-modal molecular programs regulate melanoma cell state (2022) (3)
- Human genome meeting 2016 (2016) (3)
- Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance (2022) (1)
- Clinical Success of Adoptive Cell Transfer Therapy Using Tumor Infiltrating Lymphocytes (2015) (1)
- Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. (2022) (1)
- Human genome meeting 2016 (2016) (0)
- Abstract PR15: CD74 regulated inflammatory pattern is associated with TIL growth and favorable response to adoptive immunotherapy (2020) (0)
- Metabolic plasticity of T-cell therapies: multi-omic profiling of interacting human tumor-infiltrating lymphocytes and autologous tumor adoptive cell therapy (2022) (0)
- Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy (2013) (0)
- Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy (2020) (0)
- Highlights from the literature (1963) (0)
- You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes (2015) (0)
- Integrated profiling of T cells and tumor cells demonstrates metabolic adaptation essential for melanoma cell therapy (2019) (0)
- Abstract PR03: Nongenomic BAP1 aberrancy drives highly aggressive cutaneous melanoma phenotype (2020) (0)
- 187 Multi-omic single-cell profiling demonstrates that competition for fatty acids and fatty acid oxidation enables tumor-infiltrating lymphocyte function and survival (2021) (0)
- 822 Favorable response of melanoma to TIL therapy associated with IFN-g regulated inflammatory pathway (2019) (0)
- Prognostic and biologic significance of high LCK expression in ovarian cancer (2015) (0)
- Abstract 6425: Functional roles of enhancers in immune microenvironment & immunotherapy response (2023) (0)
- The metabolic basis of resistance to Adoptive T Cell Therapy (ACT) in patients with solid tumors (2018) (0)
- Highlights from the literature (1964) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Caitlin Creasy?
Caitlin Creasy is affiliated with the following schools: